WCM Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
119,666
+7,718
| +7% | +$798K | 0.03% | 136 |
|
|
2025
Q1 | $13.3M | Sell |
111,948
-48
| -0% | -$5.69K | 0.03% | 124 |
|
|
2024
Q4 | $9.5M | Sell |
111,996
-1,696
| -1% | -$144K | 0.02% | 156 |
|
|
2024
Q3 | $10.2M | Buy |
113,692
+347
| +0.3% | +$31.1K | 0.02% | 150 |
|
|
2024
Q2 | $9.08M | Buy |
113,345
+1,755
| +2% | +$141K | 0.02% | 145 |
|
|
2024
Q1 | $8.9M | Buy |
111,590
+6,782
| +6% | +$541K | 0.02% | 144 |
|
|
2023
Q4 | $8.34M | Buy |
104,808
+8,845
| +9% | +$704K | 0.02% | 149 |
|
|
2023
Q3 | $6.71M | Buy |
95,963
+1,685
| +2% | +$118K | 0.02% | 142 |
|
|
2023
Q2 | $6.77M | Buy |
94,278
+5,733
| +6% | +$412K | 0.02% | 147 |
|
|
2023
Q1 | $5.46M | Sell |
88,545
-194
| -0.2% | -$12K | 0.02% | 154 |
|
|
2022
Q4 | $6.84M | Sell |
88,739
-44,966
| -34% | -$3.47M | 0.02% | 147 |
|
|
2022
Q3 | $5.9M | Buy |
133,705
+5,028
| +4% | +$222K | 0.02% | 143 |
|
|
2022
Q2 | $4.7M | Sell |
128,677
-15
| -0% | -$547 | 0.02% | 150 |
|
|
2022
Q1 | $5.32M | Buy |
128,692
+8,252
| +7% | +$341K | 0.01% | 144 |
|
|
2021
Q4 | $4.55M | Buy |
120,440
+46,471
| +63% | +$1.76M | 0.01% | 154 |
|
|
2021
Q3 | $2.44M | Buy |
73,969
+371
| +0.5% | +$12.2K | 0.01% | 166 |
|
|
2021
Q2 | $4.97M | Buy |
73,598
+2,934
| +4% | +$198K | 0.01% | 139 |
|
|
2021
Q1 | $4M | Sell |
70,664
-1,443
| -2% | -$81.7K | 0.01% | 143 |
|
|
2020
Q4 | $5.88M | Buy |
72,107
+197
| +0.3% | +$16.1K | 0.02% | 140 |
|
|
2020
Q3 | $5.12M | Buy |
71,910
+25,905
| +56% | +$1.85M | 0.02% | 132 |
|
|
2020
Q2 | $3.79M | Buy |
46,005
+10,484
| +30% | +$863K | 0.01% | 141 |
|
|
2020
Q1 | $2.09M | Buy |
+35,521
| New | +$2.09M | 0.01% | 147 |
|